Patents by Inventor Uwe Schuschnig
Uwe Schuschnig has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).
-
Patent number: 11666712Abstract: The invention relates to a nebulizer (1) comprising an aerosol generator (6), a nebulizing chamber (5) and an outlet (16), the aerosol generator (6) being designed to release an aerosol into the nebulizing chamber (5) and the outlet (16) being designed to allow the removal of the aerosol from the nebulizing chamber (5). To achieve a high output rate, a wetting surface (2) is provided in the nebulizing chamber (5).Type: GrantFiled: May 12, 2015Date of Patent: June 6, 2023Assignee: PARI GmbH Spezialisten für effektive InhalationInventors: Uwe Schuschnig, Ulf Krüger, Titus Selzer, Erman Lu, Emir Jelovac, Jens Gramann
-
Publication number: 20220118196Abstract: The invention relates to a nebulizer comprising an aerosol generator, a nebulizing chamber and an outlet, the aerosol generator being designed to release an aerosol into the nebulizing chamber and the outlet being designed to allow the removal of the aerosol from the nebulizing chamber. To achieve a high output rate, a wetting surface is provided in the nebulizing chamber.Type: ApplicationFiled: December 30, 2021Publication date: April 21, 2022Applicant: PARI GmbH Spezialisten für effektive InhalationInventors: Uwe Schuschnig, Ulf Krüger, Titus Selzer, Erman Lu, Emir Jelovac, Jens Gramann
-
Publication number: 20190099566Abstract: Method of generating an aerosol by means of an inhalation device for inhalation by a human or animal body, the method comprising providing liquid in the inhalation device, chemically generating gas bubbles in the liquid, bursting of the gas bubbles at the surface of the liquid, thereby generating an aerosol.Type: ApplicationFiled: October 2, 2018Publication date: April 4, 2019Applicant: PARI GmbH Spezialisten für effektive InhalationInventors: Jens Gramann, Andrea Winzen, Uwe Schuschnig
-
Patent number: 9744314Abstract: A pharmaceutical aerosol is disclosed which is suitable for delivering an active compound to the mucosa of the nose, the osteomeatal complex or a paranasal sinus. The pressure of the aerosol is not constant, but pulsates at a frequency from about 10 to 90 Hz. The aerosol is further characterised in that it exhibits a low effective flow rate of less than about 5 liters per minute. The aerosol is, inter alia, suitable for the prevention, management, or treatment of a disease, symptom, or condition affecting the nose or the paranasal sinuses, such as acute and chronic sinusitis.Type: GrantFiled: August 27, 2014Date of Patent: August 29, 2017Assignee: PARI Pharma GMBHInventors: Manfred Keller, Uwe Schuschnig, Johann Zimmermann, Martin Luber, Andreas Böhm
-
Publication number: 20170224937Abstract: The invention relates to a nebulizer (1) comprising an aerosol generator (6), a nebulizing chamber (5) and an outlet (16), the aerosol generator (6) being designed to release an aerosol into the nebulizing chamber (5) and the outlet (16) being designed to allow the removal of the aerosol from the nebulizing chamber (5). To achieve a high output rate, a wetting surface (2) is provided in the nebulizing chamber (5).Type: ApplicationFiled: May 12, 2015Publication date: August 10, 2017Applicant: PARI GmbH Spezialisten für effektive InhalationInventors: Uwe Schuschnig, Ulf Krüger, Titus Selzer, Erman Lu, Emir Jelovac, Jens Gramann
-
Patent number: 9717867Abstract: In a first aspect, the invention relates to a method for operating an aerosol inhalation device (10), comprising the steps of transporting a certain amount of an aerosol to a desired location outside said device (10) and vibrating the transported aerosol when it has reached said desired location. In a second aspect, the invention relates to an aerosol inhalation device (10) comprising a pump (1) for flowing a certain amount of an aerosol to a desired location outside the device (10), a vibrator (2) for vibrating the transported aerosol in a vibration mode and a control configured to actuate the vibrator (2) for vibrating the flowed aerosol only when it has reached said desired location.Type: GrantFiled: February 27, 2009Date of Patent: August 1, 2017Assignees: PARI GmbH Spezialisten für effektive Inhalation, PARI Pharma GmbHInventors: Martin Luber, Andreas Boehm, Uwe Schuschnig, Axel Krüner
-
Publication number: 20150027440Abstract: The invention relates to an aerosol delivery device (10, 100, 100?) comprising an aerosol generator (12, 106) for generating an aerosol in the device and a fluid conveying unit (14, 16, 18; 102, 104, 130) configured to induce a first fluid flow (26, 120) having a first flow rate in the device for transporting at least a portion of the generated aerosol outside the device and to induce a second fluid flow (32, 122) having a second flow rate in the device for conveying a fluid into the device, wherein the fluid conveying unit comprises a vibrator (18, 104) for vibrating the aerosol and the first flow rate is equal to or smaller than the second flow rate.Type: ApplicationFiled: July 29, 2014Publication date: January 29, 2015Applicant: PARI Pharma GmbHInventors: Uwe Schuschnig, Sascha Roeder
-
Publication number: 20140366872Abstract: A pharmaceutical aerosol is disclosed which is suitable for delivering an active compound to the mucosa of the nose, the osteomeatal complex or a paranasal sinus. The pressure of the aerosol is not constant, but pulsates at a frequency from about 10 to 90 Hz. The aerosol is further characterised in that it exhibits a low effective flow rate of less than about 5 litres per minute. The aerosol is, inter alia, suitable for the prevention, management, or treatment of a disease, symptom, or condition affecting the nose or the paranasal sinuses, such as acute and chronic sinusitis.Type: ApplicationFiled: August 27, 2014Publication date: December 18, 2014Inventors: Manfred Keller, Uwe Schuschnig, Johann Zimmermann, Martin Luber, Andreas Böhm
-
Patent number: 8852557Abstract: A pharmaceutical aerosol is disclosed which is suitable for delivering an active compound to the mucosa of the nose, the osteomeatal complex or a paranasal sinus. The pressure of the aerosol is not constant, but pulsates at a frequency from about 10 to 90 Hz. The aerosol is further characterized in that it exhibits a low effective flow rate of less than about 5 liters per minute. The aerosol is, inter alia, suitable for the prevention, management, or treatment of a disease, symptom, or condition affecting the nose or the paranasal sinuses, such as acute and chronic sinusitis.Type: GrantFiled: August 29, 2008Date of Patent: October 7, 2014Assignee: PARI Pharma GmbHInventors: Manfred Keller, Uwe Schuschnig, Johann Zimmermann, Martin Luber, Andreas Böhm
-
Publication number: 20130112197Abstract: The invention relates to a method for operating an aerosol delivery device (10), comprising the steps of generating a predetermined amount of an aerosol in the device (10) and inducing a transport flow in the device (10) for transporting at least a portion of the predetermined amount of the aerosol outside the device (10). During the aerosol generating step, the transport flow is first induced, then stopped after a predetermined first period of time and then induced again after a predetermined second period of time.Type: ApplicationFiled: April 26, 2011Publication date: May 9, 2013Applicant: PARI Pharma GmbHInventors: Axel Krüner, Elisabeth Klopfer, Uwe Schuschnig, René Seifert
-
Patent number: 8347878Abstract: Aerosol therapy device comprising a nebuliser (10) for generating an aerosol and forming an aerosol flow, a first nosepiece (11) for introducing the aerosol flow into one of the two nostrils (12) of a user, a pressure fluctuation source for generating a pressure fluctuation (DS), a second nosepiece (14) for introducing the pressure fluctuation into the other of the two nostrils (15) of the user in order to superimpose the pressure fluctuation and the aerosol flow, and a sensor system comprising a first pressure sensor (19) for detecting the signal of the pressure fluctuation that arrives at the first nosepiece (11), and an evaluation means (18) that concludes the degree of closure of the velum of the user based on the signal.Type: GrantFiled: April 7, 2008Date of Patent: January 8, 2013Assignee: PARI GmbH Spezialisten für effektive InhalationInventors: Uwe Schuschnig, Martin Luber, Wolfgang Achtzehner
-
Publication number: 20100316576Abstract: A pharmaceutical aerosol is disclosed which is suitable for delivering an active compound to the mucosa of the nose, the osteomeatal complex or a paranasal sinus. The pressure of the aerosol is not constant, but pulsates at a frequency from about 10 to 90 Hz. The aerosol is further characterised in that it exhibits a low effective flow rate of less than about 5 litres per minute. The aerosol is, inter alia, suitable for the prevention, management, or treatment of a disease, symptom, or condition affecting the nose or the paranasal sinuses, such as acute and chronic sinusitis.Type: ApplicationFiled: August 29, 2008Publication date: December 16, 2010Applicant: PARI PHARMA GMBHInventors: Manfred Keller, Uwe Schuschnig, Johann Zimmermann, Martin Luber, Andreas Böhm
-
Publication number: 20080251068Abstract: Aerosol therapy device comprising a nebuliser (10) for generating an aerosol and forming an aerosol flow, a first nosepiece (11) for introducing the aerosol flow into one of the two nostrils (12) of a user, a pressure fluctuation source for generating a pressure fluctuation (DS), a second nosepiece (14) for introducing the pressure fluctuation into the other of the two nostrils (15) of the user in order to superimpose the pressure fluctuation and the aerosol flow, and a sensor system comprising a first pressure sensor (19) for detecting the signal of the pressure fluctuation that arrives at the first nosepiece (11), and an evaluation means (18) that concludes the degree of closure of the velum of the user based on the signal.Type: ApplicationFiled: April 7, 2008Publication date: October 16, 2008Applicant: PARI GmbH Spezialisten fuer effektive InhalationInventors: Uwe Schuschnig, Martin Luber, Wolfgang Achtzehner
-
Publication number: 20070202051Abstract: A pharmaceutical aerosol is disclosed which is suitable for delivering an active compound to the mucosa of the nasal cavity or of the paranasal sinuses. The aerosol is characterised in that its pressure is not constant, but pulsates at a frequency of about 10 to 90 Hz. The mass median diameter of the dispersed phase is from about 2 to 6 ?m, and the volume of about 5 mL or less of the dispersed phase comprises a unit dose of an active compound. The aerosol is, inter alia, suitable for the prevention, management, or treatment of a disease, symptom, or condition affecting the nose or the paranasal sinuses, such as acute and chronic sinusitis.Type: ApplicationFiled: February 9, 2007Publication date: August 30, 2007Applicant: Pari GmbHInventor: Uwe Schuschnig